p.DOM-WT1-37 DNA Vaccine and p.DOM-WT1-126 DNA Vaccine
RHMCAN0700
Phase 2 mab completed
Quick answer
p.DOM-WT1-37 DNA Vaccine and p.DOM-WT1-126 DNA Vaccine for Leukaemia (Acute) is a Phase 2 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INOVIO PHARMACEUTICALS, INC.
- Indication
- Leukaemia (Acute)
- Phase
- Phase 2
- Modality
- mab
- Status
- completed